Real-World Evidence in Alopecia Areata Treatment: A Narrative Review

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Lasers and energy-assisted methods show promise for treating hair loss, but more research is needed.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Fractional lasers effectively treat alopecia areata, especially when combined with minoxidil or cortisol.

Both treatments for resistant alopecia areata were equally effective.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

Baricitinib is effective and safe for treating severe alopecia areata.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

5 mg/mL of triamcinolone acetonide is most effective for hair regrowth with fewer side effects.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Hydroxychloroquine may help treat alopecia areata in children.

Dupilumab for eczema may cause hair loss.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

BD 1/4 dilution is the best for treating localized alopecia areata in adults.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Multiple courses of pulse corticosteroid therapy improve hair growth in alopecia areata patients with minimal side effects.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

The combined therapy was effective and safe for children with severe alopecia areata.

Using 2.5 mg/mL triamcinolone acetonide is effective for hair growth in alopecia areata with fewer side effects.

The excimer lamp is a safe and effective treatment for severe alopecia areata.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Clobetasol propionate, 0.05%, is more effective and safe for treating childhood alopecia areata than hydrocortisone, 1%.

Oral cyclosporine can help regrow hair in severe alopecia areata cases.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Careful patient selection is key for effective pulse corticosteroid treatment in children with alopecia areata.

Alopecia areata is a common autoimmune disease affecting hair follicles, with unclear causes and a need for better treatments.

Sulfasalazine may help treat persistent alopecia areata.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Alopecia areata mainly affects young people and has significant psychological impacts, especially in males.

Sulfasalazine may help regrow hair in severe alopecia areata cases.